Eureka Herba Indonesia
https://eurekabiomedical.com/index.php/EHI
<p><strong>Eureka Herba Indonesia (EHI)</strong> is open access peer-reviewed international scholarly journal that focused in publish all research related herbal medicine, complementary therapy, and new modalities therapeutic using herbs and mineral, especially from Indonesia and world.</p> <p><strong>Eureka Herba Indonesia (EHI)</strong> aimed to publish a high-quality scientific paper including original research papers, reviews, short communication, and technical notes. <strong>Eureka Herba Indonesia (EHI)</strong> is published by <a href="https://drive.google.com/file/d/1sXSYUhRS-9wCWSbqAzwyQQUgl7tRc1Pa/view?usp=sharing" target="_blank" rel="noopener">Asosiasi Peneliti Herbal Indonesia (APHI)</a>, <a href="https://cattleyacenter.id/" target="_blank" rel="noopener">CMHC (Research & Sains Center)</a> and <a href="https://cattleyapublicationservices.com/hanifmedisiana/" target="_blank" rel="noopener">HM Publisher</a>. Eureka Herba Indonesia has eISSN, <a href="https://issn.brin.go.id/terbit/detail/1604048177" target="_blank" rel="noopener">2746-5152</a>. <strong>Eureka Herba Indonesia (EHI) </strong>also has <a href="https://portal.issn.org/resource/ISSN/2746-5152#" target="_blank" rel="noopener">International ISSN 2746-5152</a>.</p> <p> </p> <p style="text-align: center;"><a href="https://portal.issn.org/resource/ISSN/2746-5152#" target="_blank" rel="noopener"><img src="/public/site/images/admin/road.png" width="250" height="83"></a></p>HM Publisheren-USEureka Herba Indonesia2746-5152<p>1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="https://creativecommons.org/licenses/by-sa/4.0/" target="_blank" rel="noopener">Creative Commons Attribution License</a> that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</p> <p>2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</p> <p>3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.</p>Comparison of the Effectiveness of Kencur Warm Water Soaking with Salt Warm Water Against Leg Edema of Third Trimester Pregnant Women in the Working Area of Rawang Health Center, Indonesia
https://eurekabiomedical.com/index.php/EHI/article/view/114
<p>Leg edema is a common complaint in third trimester pregnant women. It is believed that soaking in kencur warm water and salt warm water can help overcome this. Comparing the effectiveness of soaking in warm kencur water with warm salt water on leg edema in third trimester pregnant women. Quasi-experimental research with a pretest-posttest design with the control group. A total of 60 third trimester pregnant women were divided into two groups: the kencur warm water immersion group (n=30) and the salt warm water immersion group (n=30). The intervention was carried out for 15 minutes, twice a day for 3 days. Leg edema was measured using a measuring tape before and after the intervention. There was a significant reduction in leg edema in both groups after intervention (p<0.05). The reduction in leg edema in the kencur warm water immersion group was greater than in the salt warm water immersion group (p<0.05). Kencur warm water soaks are more effective than salt warm water soaks in reducing leg edema in third-trimester pregnant women.</p>Riri ApriantiSintia Hikma Oktavia
Copyright (c)
2024-02-122024-02-125243243510.37275/ehi.v5i1.114Antibacterial Effectiveness Test of Methanol Extract of Red Galangal Rhizome (Alpinia purpurata (Vieill) K. Schum) Against Streptococcus pyogenes and Klebsiella pneumonia Bacteria
https://eurekabiomedical.com/index.php/EHI/article/view/116
<p>Red galangal rhizome (<em>Alpinia purpurata</em> (Vieill) K. Schum) is a medicinal plant belonging to the family <em>Zingiberaceae</em>. Red galangal rhizomes have antibacterial benefits because they contain active substances such as flavonoids, saponins, triterpenoids, alkaloids, and tannins. <em>Streptococcus pyogenes </em>causes bacterial infections of the skin and upper respiratory tract, while <em>Klebsiella pneumonia</em> is the bacteria that causes pneumonia. This study aims to determine the antibacterial effectiveness of methanol extract of red galangal rhizomes (<em>Alpinia purpurata</em> (Vieill) K. Schum) against <em>Streptococcus pyogenes</em> and <em>Klebsiella pneumonia</em> bacteria. This research is an experimental laboratory with a post-test-only controlled group design. Red galangal rhizomes were extracted using methanol solvent and tested for antibacterial effectiveness using the well method. There were 6 groups in the study, namely the chloramphenicol positive control group, the distilled water negative control group, and the 20%, 40%, 60%, and 80% concentration groups. The largest inhibition zone diameter was found at a concentration of 80%, with an average of 25.50 mm in <em>Streptococcus pyogenes</em> bacteria and 28.73 mm in <em>Klebsiella pneumonia</em> bacteria. In conclusion, methanol extract of red galangal rhizome (<em>Alpinia purpurata</em> (Vieill) K. Schum) effective against bacteria <em>Streptococcus pyogenes</em> and <em>Klebsiella pneumonia</em>.</p>Dwi Permatasari Utomo PutriListiana Masyita DewiRochmadina Suci BestariNurhayani
Copyright (c)
2024-02-222024-02-225243644010.37275/ehi.v5i2.116Potential of Legetan Leaves (Acmella oleracea) as a Therapeutic Modality for Osteoarthritis: An In Vivo Study
https://eurekabiomedical.com/index.php/EHI/article/view/117
<p>Osteoarthritis (OA) is a degenerative joint disease characterized by inflammation and cartilage damage. Legetan leaves (<em>Acmella oleracea</em>) have anti-inflammatory and antioxidant potential that may help relieve OA symptoms. This study aims to evaluate the potential of legetan leaves as a therapeutic modality for OA in a rat model. Legetan leaf extract was formulated into an oral preparation and given to rats induced by OA with monosodium iodate. The positive control group received standard OA medications. Parameters measured include pain scores, joint inflammation, and cartilage damage. Legetan leaf extract significantly reduced pain scores and joint inflammation in rats with OA. Legetan leaf extract also shows a protective effect against cartilage damage. In conclusion, Legetan leaves have potential as a therapeutic modality for OA.</p>Indrayani Indrayani
Copyright (c)
2024-03-062024-03-065244144510.37275/ehi.v5i2.117Analysis of Ethnopharmacological Studies on the Use of the Sambiloto Plant in the Treatment of Malaria in the Asmat Tribal Community in Papua, Indonesia
https://eurekabiomedical.com/index.php/EHI/article/view/118
<p>Malaria is still a major health problem in Indonesia, especially in the Papua region. The Asmat tribe has traditional knowledge about the use of medicinal plants to treat malaria, one of which is sambiloto. This research uses a qualitative observational research design with an ethnopharmacological approach. This approach combines aspects of ethnography and pharmacology to study traditional knowledge and the use of medicinal plants in a community. It was discovered that sambiloto has long been used by the Asmat tribe to treat malaria. Sambiloto leaf is processed into a decoction or juice and drunk to relieve malaria symptoms such as fever, chills, and headaches. This ethnopharmacological study shows that sambiloto has potential as an herbal medicine for treating malaria in the Asmat community. Further research is needed to test the effectiveness and safety of sambiloto in the treatment of malaria.</p>Esther Lea AwotauwRuth Maria Panggabean
Copyright (c)
2024-03-072024-03-075244645110.37275/ehi.v5i2.118Conservation and Exploration of the Potential of Rare Medicinal Plants in the Tropical Rainforest of Bukit Barisan, Sumatra, Indonesia: An Effort Towards Sustainable Herbal Medicine
https://eurekabiomedical.com/index.php/EHI/article/view/119
<p>The Bukit Barisan tropical rainforest in Sumatra, Indonesia, is one of the most biodiverse areas in the world. It is estimated that there are more than 10,000 plant species in this forest, and many of them have potential as herbal medicines. However, deforestation and overexploitation threaten the preservation of medicinal plants in the Bukit Barisan tropical rainforest. This causes loss of valuable natural resources and hinders research and development of new herbal medicines. This research was conducted in several tropical rainforests in Bukit Barisan, Sumatra. Field surveys were conducted to document rare medicinal plant species. Plant samples were collected and analyzed for their phytochemical content. Bioassay tests were carried out to evaluate antibacterial, antioxidant and anti-inflammatory activities. Strategies for conservation and sustainable exploration of rare medicinal plants are developed based on research results. Field surveys found 27 species of rare medicinal plants. Phytochemical analysis shows that this plant contains various bioactive compounds, such as alkaloids, flavonoids and terpenoids. Bioassay tests show that this plant has significant antibacterial, antioxidant and anti-inflammatory activity. In conclusion, the Bukit Barisan tropical rainforest has great potential for the development of herbal medicine. Sustainable conservation and exploration of rare medicinal plants in the Bukit Barisan tropical rainforest is important to ensure the preservation of these valuable natural resources and to improve community health.</p>Syaidina Maulana
Copyright (c)
2024-03-082024-03-085245245910.37275/ehi.v5i2.119Analysis of Ethnopharmaceutical Studies of Traditional Medicine for the Management of Jaundice Due to Hepatic Disorders by the Mandar Tribe of West Sulawesi, Indonesia
https://eurekabiomedical.com/index.php/EHI/article/view/120
<p>Jaundice, or icterus, is a medical condition characterized by yellowing of the skin and whites of the eyes. This is caused by a buildup of bilirubin in the blood, which is a waste product of the breakdown of red blood cells. Liver disorders, such as hepatitis, are the most common cause of jaundice. The Mandar tribe in West Sulawesi Indonesia has a traditional healing tradition that has been passed down from generation to generation. This traditional medicine is often used to treat various diseases, including jaundice. This study aims to analyze the ethnopharmaceutical traditional treatment for jaundice in the Mandar tribe in West Sulawesi. This research used a descriptive observational method with traditional healthcare respondents. Data was collected through interviews and observations of traditional healers and patients who used traditional medicine. The data was analyzed descriptively to determine the type of plant, part of the plant used, processing methods, and how traditional medicines are used. This research found 14 plant species from 13 families that were used as medicine for jaundice. Two types of plants are typically used by the Mandar tribe, namely lapo-lapo (<em>Melanolepis multiglandulosa</em>) and barorang (<em>Blumea balsamifera</em>). The parts of the plant most commonly used as medicine are leaves (43%), followed by fruit (29%), stems (14%), roots (7%), rhizomes (4%), and herbs (3%). Plant processing by pressing and boiling is the most widely used (50% each). The most common method of use is boiling (70%), followed by pounding (20%) and eating directly (10%). This research found 14 plant species from 13 families that were used by the Mandar tribe as medicine for jaundice. Two types of plants are typically used, namely lapo-lapo and barorang. This research provides important information about the Mandar tribe's ethnopharmacology for jaundice and can be a basis for the development of more effective and safer traditional medicines.</p>Dewi Weni SariKharisma Jayak PratamaAnnora Rizky Amalia
Copyright (c)
2024-05-082024-05-085246046910.37275/ehi.v5i2.120